About HS Code 3002
Heading 3002 covers a critical range of biological pharmaceuticals: "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc." This classification is pivotal for global health and encompasses products vital for disease prevention, treatment, and diagnosis. The scope is broad, including whole blood, plasma, albumin, immunoglobulins, clotting factors, and a wide array of immunological products such as vaccines, antitoxins, and monoclonal antibodies. It also covers cultures of microorganisms (excluding yeasts) used for therapeutic, prophylactic, or diagnostic purposes. The phrase "modified or obtained by biotechnological processes" highlights the advanced scientific methods used in their production. This classification is paramount for trade compliance due to the high regulatory scrutiny, cold chain requirements, and significant public health implications. Accurate classification ensures adherence to national and international health regulations, proper storage, and efficient distribution. Historically, this heading reflects the evolution from traditional blood transfusions and vaccine production to sophisticated biotechnology-derived therapies. It forms a cornerstone of Chapter 30, emphasizing its role in modern medicine and global disease control within Section VI.
Products Under This Code
Human plasma, Human albumin, Immunoglobulin G (IVIG), Factor VIII concentrates, Tetanus antitoxin, Diphtheria antitoxin, Antivenoms, Influenza vaccines, Measles-Mumps-Rubella (MMR) vaccines, Polio vaccines, COVID-19 vaccines, Bacterial cultures for vaccine production, Viral cultures for diagnostic kits, Monoclonal antibodies (e.g., trastuzumab, rituximab), Polyclonal antibodies, Interferons (e.g., interferon alpha), Interleukins, Diagnostic reagents containing blood fractions, Animal blood for diagnostic use, Bovine serum albumin (BSA) for therapeutic/diagnostic use, Recombinant therapeutic proteins (e.g., insulin if classified here), Cell culture media with blood components, Toxoids, Bacterial toxins for therapeutic use, Human growth hormone (recombinant)
Real World Examples
A pharmaceutical giant in Belgium exports millions of doses of COVID-19 vaccines via air cargo to various public health agencies across Africa and South America. In another instance, a specialized blood products company in the United States ships bulk human plasma fractions, such as albumin and immunoglobulins, to a manufacturing facility in Ireland for purification and formulation into injectable therapeutic drugs. Furthermore, a veterinary pharmaceutical firm in the Netherlands imports equine tetanus antitoxin from Argentina, intended for prophylactic use in livestock.
Common Misclassification
Common errors include confusing diagnostic reagents under 3002 with general laboratory reagents under 3822 if they do not contain human/animal blood or immunological products. Another mistake is classifying active ingredients for vaccines or antibodies (Chapter 29) instead of the finished immunological product (3002). The key is the explicit 'therapeutic, prophylactic or diagnostic uses' and the specific nature of blood, blood fractions, immunological products, or microorganism cultures. Non-therapeutic uses of blood (e.g., for food or feed) would fall under other chapters like 05 or 35.
Subheadings 10
Industry
This code belongs to the Chemicals industry.
Trade Overview
The global trade in 3002 products is dominated by major pharmaceutical and biotechnology hubs such as the United States, European Union (especially Germany, Switzerland, Belgium), Japan, and increasingly China and India. These countries are both significant producers and consumers. Regulations are extremely stringent due to public health and safety concerns. Tariffs are typically very low or zero in most countries to ensure widespread access to essential medicines, vaccines, and diagnostic tools, reflecting their critical role in global health security. Trade agreements often include specific provisions to facilitate the movement of these sensitive goods.
Frequently Asked Questions
What is HS code 3002?
HS code 3002 is a 4-digit heading in the Harmonized System that covers: Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc. Heading 3002 covers a critical range of biological pharmaceuticals: "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc." This classification is pivotal for global health and encompasses products vital for disease prevention, treatment, and diagnosis. The scope is broad, including whole blood, plasma, albumin, immunoglobulins, clotting factors, and a wide array of immunological products such as vaccines, antitoxins, and monoclonal antibodies. It also covers cultures of microorganisms (excluding yeasts) used for therapeutic, prophylactic, or diagnostic purposes. The phrase "modified or obtained by biotechnological processes" highlights the advanced scientific methods used in their production. This classification is paramount for trade compliance due to the high regulatory scrutiny, cold chain requirements, and significant public health implications. Accurate classification ensures adherence to national and international health regulations, proper storage, and efficient distribution. Historically, this heading reflects the evolution from traditional blood transfusions and vaccine production to sophisticated biotechnology-derived therapies. It forms a cornerstone of Chapter 30, emphasizing its role in modern medicine and global disease control within Section VI.
What products fall under HS code 3002?
Human plasma, Human albumin, Immunoglobulin G (IVIG), Factor VIII concentrates, Tetanus antitoxin, Diphtheria antitoxin, Antivenoms, Influenza vaccines, Measles-Mumps-Rubella (MMR) vaccines, Polio vaccines, COVID-19 vaccines, Bacterial cultures for vaccine production, Viral cultures for diagnostic kits, Monoclonal antibodies (e.g., trastuzumab, rituximab), Polyclonal antibodies, Interferons (e.g., interferon alpha), Interleukins, Diagnostic reagents containing blood fractions, Animal blood for diagnostic use, Bovine serum albumin (BSA) for therapeutic/diagnostic use, Recombinant therapeutic proteins (e.g., insulin if classified here), Cell culture media with blood components, Toxoids, Bacterial toxins for therapeutic use, Human growth hormone (recombinant)
What are common misclassifications for HS code 3002?
Common errors include confusing diagnostic reagents under 3002 with general laboratory reagents under 3822 if they do not contain human/animal blood or immunological products. Another mistake is classifying active ingredients for vaccines or antibodies (Chapter 29) instead of the finished immunological product (3002). The key is the explicit 'therapeutic, prophylactic or diagnostic uses' and the specific nature of blood, blood fractions, immunological products, or microorganism cultures. Non-therapeutic uses of blood (e.g., for food or feed) would fall under other chapters like 05 or 35.
Which countries trade the most under HS code 3002?
The global trade in 3002 products is dominated by major pharmaceutical and biotechnology hubs such as the United States, European Union (especially Germany, Switzerland, Belgium), Japan, and increasingly China and India. These countries are both significant producers and consumers. Regulations are extremely stringent due to public health and safety concerns. Tariffs are typically very low or zero in most countries to ensure widespread access to essential medicines, vaccines, and diagnostic tools, reflecting their critical role in global health security. Trade agreements often include specific provisions to facilitate the movement of these sensitive goods.
How is HS code 3002 structured?
HS code 3002 is a 4-digit heading under Chapter 30 of the Harmonized System. The first 2 digits (30) identify the chapter, and digits 3-4 (02) specify the heading. This code contains multiple 6-digit subheadings for precise product classification.